(Q22121985)

PubMed

PubMed publication ID

18167503

Clinical Pharmacology & Therapeutics

7 February 2023

language of work or name

English

0 references

publication date

2 January 2008

0 references

published in

0 references

volume

83

0 references

issue

2

0 references

page(s)

349-353

0 references

cites work

A path to improved pharmaceutical productivity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Clinical biomarkers in drug discovery and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Molecular imaging in drug discovery and development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigm

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Emerging concepts in molecular MRI.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

The opportunities and challenges of developing imaging biomarkers to study lung function and disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

In vivo imaging of siRNA delivery and silencing in tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Optical molecular imaging in drug discovery and clinical development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Small animal imaging in drug development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Molecular neuroimaging: from conventional to emerging techniques.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

A role for fMRI in optimizing CNS drug development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Neuropeptide Y5 receptor antagonism does not induce clinically meaningful weight loss in overweight and obese adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Lack of efficacy of the substance p (neurokinin1 receptor) antagonist aprepitant in the treatment of major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Overview of early response assessment in lymphoma with FDG-PET.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

Molecular imaging of cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100467

7 January 2021